ArticleRheumatology and therapy2017

Adalimumab with Methotrexate in Treatment-Naïve Japanese Patients with Rheumatoid Arthritis at Risk of Progressive Structural Joint Damage: A Postmarketing Observational Study.

Yukiko Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.